Are Different Populations Fairly Represented in Single-Cell Omic Atlases?
Catrina Yang1, Kavitharini Saravanan2, Aryan Saharan3
1University of Oxford, Green Templeton College, Medical Sciences Division, Oxford, OX2 6HG, UK.
Biorxiv : the Preprint Server for Biology
|June 4, 2026
Summary
Single-cell atlases show significant European over-representation and under-representation of other groups, risking health inequities. This study provides a checklist to promote diversity in future single-cell research.
Area of Science:
- Genomics
- Computational Biology
- Population Health
Background:
- Single-cell omic atlases are revolutionizing biological and medical research.
- Systematic evaluation of demographic representativeness in these atlases is lacking.
- Existing atlases may perpetuate health disparities due to skewed representation.
Purpose of the Study:
- To systematically evaluate the demographic representativeness of major single-cell atlases.
- To identify and quantify population under-representation and over-representation.
- To propose actionable strategies for improving diversity in single-cell research.
Main Methods:
- Analysis of over 13,500 samples from Human Cell Atlas (HCA), Human Tumor Atlas Network (HTAN), and PsychAD Consortium.
- Benchmarking atlas demographics against global and US general and disease-prevalence data.
- Assessment of ancestry and sex representation within annotated samples.
Main Results:
- Pervasive over-representation of European ancestry and under-representation of Asian and Latino individuals across atlases.
- Nearly 70% of HCA samples lacked ancestry annotation; annotated samples showed a sixfold European over-representation.
- HTAN tumors were 69% European, with some cancer types exhibiting sex skews.
- PsychAD was nearly two-thirds European.
Conclusions:
- Current single-cell resources risk embedding inequities into AI, biomarker discovery, and therapeutics.
- Disparities in demographic representation can exacerbate existing health inequities.
- An actionable checklist is provided to guide researchers in designing more equitable single-cell studies.


